PolyPid names interim board chairman, updates filings

PolyPid Ltd. reports a leadership change and links recent financial disclosures to its U.S. registration statements.

Rhea-AI Filing Summary

PolyPid Ltd. reports a leadership change and links recent financial disclosures to its U.S. registration statements. The company notes that Jacob Harel’s service as director and chairman ended at the June 25, 2025 shareholder meeting. On August 11, 2025, the board elected existing director Nir Dror as Interim Chairman of the Board, to serve until further notice or another board decision.

The filing also records that on August 13, 2025 PolyPid issued a press release titled “PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results.” Specified sections of that release, including corporate highlights, financial results for the three and six months ended June 30, 2025, balance sheet highlights, forward-looking statements and the attached financial statements, are incorporated by reference into several of PolyPid’s Form F-3 and Form S-8 registration statements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What leadership change did PolyPid (PYPD) report in this 6-K?

PolyPid reported that its board elected director Nir Dror as Interim Chairman of the Board on August 11, 2025. He replaces Jacob Harel, whose service as director and chairman ended at the June 25, 2025 shareholder meeting.

When did Jacob Harel’s service as PolyPid (PYPD) chairman end?

PolyPid states that Jacob Harel’s service as a director and chairman ended at the company’s Annual and Extraordinary General Meeting of Shareholders on June 25, 2025. This termination had been previously disclosed and is referenced again in this 6-K filing.

What new role did Nir Dror assume at PolyPid (PYPD)?

Nir Dror, a director since May 2020, was elected Interim Chairman of the Board on August 11, 2025. He will serve in this interim role until further notice or another decision is made by the board of directors.

What press release is attached to PolyPid’s August 2025 Form 6-K?

The 6-K attaches a press release titled “PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results” issued on August 13, 2025. It includes recent corporate highlights, Q2 2025 financial results, balance sheet information and forward-looking statements.

How does PolyPid’s 6-K affect its Form F-3 and Form S-8 registrations?

PolyPid incorporates specific sections of the August 13, 2025 press release and its financial statements by reference into multiple Form F-3 and Form S-8 registration statements. This makes those corporate and financial updates legally part of the referenced registration statements.

Which financial periods are discussed in the press release referenced by PolyPid (PYPD)?

The referenced press release covers financial results for the three and six months ended June 30, 2025 and provides Balance Sheet Highlights. These sections, along with forward-looking statements and financial statements, are incorporated by reference into the company’s registration statements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2025 - 07:35 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of: August 2025 (Report No. 2)

Commission File Number: 001-38428

PolyPid Ltd.

(Translation of registrant’s name into English)

18 Hasivim Street

Petach Tikva 495376, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

As previously disclosed, on June 25, 2025, the service of Jacob Harel as a director and the chairman of the board of directors (the “Board”) of PolyPid Ltd. (the “Company”) terminated at the Company’s Annual and Extraordinary General Meeting of Shareholders.

On August 11, 2025, the Board elected Nir Dror, who has been serving as a director of the Board since May 2020, to the role of Interim Chairman of the Board to serve in this role until further notice or decision by the Board.

On August 13, 2025, the Company issued a press release, titled “PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results.”

The first paragraph above of this Report of Foreign Private Issuer on Form 6-K and the bullet points under the section titled “Recent Corporate Highlights,” the sections titled “Financial results for the three months ended June 30, 2025,” “Financial results for the six months ended June 30, 2025,” “Balance Sheet Highlights,” and “Forward-looking Statements” and the financial statements in the press release attached hereto as Exhibit 99.1 are incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-276826, File No. 333-280658, File No. 333-281863, File No. 333-284376) and Form S-8 (File No. 333-239517, File No. 333-271060, File No. 333-277703 and File No. 333-280662) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished. 

1

EXHIBIT INDEX

Exhibit No.
99.1		Press release issued by PolyPid Ltd. on August 13, 2025, titled “PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results.”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	POLYPID LTD.
Date: August 13, 2025	By:	/s/ Dikla Czaczkes Akselbrad
		Name	Dikla Czaczkes Akselbrad
		Title:	Chief Executive Officer

3